Inhibikase Therapeutics (IKT) FCF Margin Growth (1y) (2021 - 2023)
Inhibikase Therapeutics (IKT) FCF Margin Growth (1y) (2021 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Inhibikase Therapeutics | 55.25 Mn | -115.12 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -34.42 Bn |
| Sep 30, 2023 | 7.31 Mn |
| Jun 30, 2023 | 6.26 Mn |
| Mar 31, 2023 | -70,926.00 |
| Dec 31, 2022 | 20.51 Mn |
| Sep 30, 2022 | -7.76 Mn |
| Jun 30, 2022 | -6.62 Mn |
| Mar 31, 2022 | -826,726.00 |
| Dec 31, 2021 | -21.01 Mn |
| Sep 30, 2021 | -81,556.00 |
| Jun 30, 2021 | -31,022.00 |
| Mar 31, 2021 | -18,526.00 |